Insider · CIK 0002023538
Sarah Nemec
Files at BOLT (Bolt Biotherapeutics, Inc.). First filing May 5, 2025, latest Sep 21, 2026.
Sarah Nemec files SEC Form 4 as officer at BOLT (Bolt Biotherapeutics, Inc.). Since May 5, 2025, Sarah Nemec has reported 4 open-market buys worth $6,070 and 1 open-market sell worth $26k, the latest filed on Sep 21, 2026.
A track record needs three past buys with six months of prices behind them; Sarah Nemec has 0, so none is measured yet.
The newest scored trade: bought $1,973 of BOLT on Jun 5, 2026, filed Sep 21, 2026, scored 29 (weak). In the last 12 months: 3 buys worth $3,235 and 1 sell worth $26k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BOLT: Bolt Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | Bolt Biotherapeutics, Inc. | $1,973 509 shares | +36% | - | |
| 45Moderate | Bolt Biotherapeutics, Inc. | $26k 7,842 shares | -31% | - | |
| 34Weak | Bolt Biotherapeutics, Inc. | $576 125 shares | +10% | +20% from low-56% from high | |
| 34Weak | Bolt Biotherapeutics, Inc. | $687 125 shares | +15% | +10% from low-52% from high | |
| 29Weak | Bolt Biotherapeutics, Inc. | $2,835 5,000 shares | +44% | - |
Transactions
Every row this insider has filed, 29 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | BOLT Bolt Biotherapeutics, Inc. | POpen-market purchase Common Stock | +509 | $3.88 | $1,973 | 1,924 | 22 d ago |
| Sep 16, 2026 | BOLT Bolt Biotherapeutics, Inc. | SOpen-market sale Common Stock | -843 | $3.77 | $3,181 | 24,081 | 22 d ago |
| Sep 17, 2026 | BOLT Bolt Biotherapeutics, Inc. | SOpen-market sale Common Stock | -2,922 | $3.32 | $9,696 | 21,159 | 22 d ago |
| Sep 18, 2026 | BOLT Bolt Biotherapeutics, Inc. | SOpen-market sale Common Stock | -4,077 | $3.24 | $13k | 17,082 | 22 d ago |
| Dec 5, 2025 | BOLT Bolt Biotherapeutics, Inc. | POpen-market purchase Common Stock | +125 | $4.61 | $576 | 1,415 | Feb 4, 2026 |
| Jan 28, 2026 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +8,000 | $0.00 | $0 | 8,000 | Feb 4, 2026 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +1,236 | - | - | 1,236 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -1,236 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +375 | - | - | 375 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -375 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +600 | - | - | 600 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -600 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +2,199 | - | - | 2,199 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -2,199 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +6,699 | - | - | 6,699 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -6,699 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +1,589 | - | - | 1,589 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -1,589 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +2,499 | - | - | 2,499 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -2,499 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +4,499 | - | - | 4,499 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -4,499 | - | - | 0 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +11,299 | - | - | 11,299 | Dec 16, 2025 |
| Dec 12, 2025 | BOLT Bolt Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -11,299 | - | - | 0 | Dec 16, 2025 |
| Jun 6, 2025 | BOLT Bolt Biotherapeutics, Inc. | POpen-market purchase Common Stock | +125 | $5.49 | $687 | 943 | Oct 24, 2025 |
| Oct 22, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Common Stock | +23,000 | $0.00 | $0 | 23,943 | Oct 24, 2025 |
| Dec 16, 2024 | BOLT Bolt Biotherapeutics, Inc. | POpen-market purchase Common Stock | +2,500 | $0.50 | $1,241 | 16,633 | May 5, 2025 |
| Jun 6, 2024 | BOLT Bolt Biotherapeutics, Inc. | POpen-market purchase Common Stock | +2,500 | $0.64 | $1,594 | 13,863 | May 5, 2025 |
| May 1, 2025 | BOLT Bolt Biotherapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +226,000 | $0.00 | $0 | 226,000 | May 5, 2025 |
Questions about Sarah Nemec
Answered from the filings on this page, as of the latest one.
Is Sarah Nemec buying or selling?
In the last 12 months Sarah Nemec reported 3 open-market buys worth $3,235 and 1 open-market sell worth $26k on SEC Form 4; the latest was bought $1,973 of BOLT on Jun 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Sarah Nemec's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sarah Nemec has 0.
Where does Sarah Nemec file Form 4?
Sarah Nemec has filed Form 4 at BOLT (Bolt Biotherapeutics, Inc.) as Senior VP, Finance and PAO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.